AlTi Global Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,942 shares of the healthcare conglomerate's stock after selling 3,038 shares during the period. AlTi Global Inc.'s holdings in UnitedHealth Group were worth $6,779,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Copia Wealth Management bought a new stake in UnitedHealth Group in the 4th quarter worth about $42,000. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group in the 1st quarter worth about $42,000. Finally, Investment Management Corp VA ADV bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $44,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Insider Buying and Selling
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.28% of the company's stock.
Analysts Set New Price Targets
A number of brokerages recently commented on UNH. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays increased their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday. Bank of America raised their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Finally, Truist Financial cut their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research note on Wednesday, July 16th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $354.86.
Read Our Latest Analysis on UNH
UnitedHealth Group Stock Performance
Shares of UNH stock traded up $4.72 during trading hours on Friday, reaching $315.10. The company had a trading volume of 14,093,579 shares, compared to its average volume of 17,031,034. The business has a fifty day moving average price of $288.78 and a 200-day moving average price of $374.41. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm has a market cap of $285.38 billion, a PE ratio of 13.65, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. The business's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.